FTSE 100 movers: Halma jumps on results; Entain, NatWest go ex-div
London's FTSE 100 was down 0.2% at 8,524.47 in afternoon trade on Thursday.
Entain and NatWest were both weaker as they traded without entitlement to the dividend.
Halma jumped after saying it expects an adjusted EBIT margin modestly above 21% for the full year to March 2025, compared to prior guidance of around 21%.
Matt Britzman, senior equity analyst at Hargreaves Lansdown, said: "Halma, a FTSE 100 leader in life-saving technologies, has delivered yet another robust trading update, putting it firmly on course for an impressive 22nd consecutive year of record profits.
"Despite navigating tricky economic and geopolitical conditions, Halma's resilient business model and agile operations mean margins are better than expected, and that should mean profit expectations for the year can tick higher.
"In today's volatile environment, steady and dependable businesses like Halma - while not always headline-grabbing - offer investors an attractive blend of quality and reliability when it's needed the most."
FTSE 100 - Risers
Vodafone Group (VOD) 72.66p 3.71%
Antofagasta (ANTO) 1,791.00p 1.85%
Halma (HLMA) 2,687.00p 1.78%
Airtel Africa (AAF) 149.40p 1.70%
AstraZeneca (AZN) 11,842.00p 1.65%
Imperial Brands (IMB) 2,779.00p 1.53%
Shell (SHEL) 2,605.00p 1.42%
BT Group (BT.A) 154.75p 1.31%
Aviva (AV.) 545.20p 1.23%
Rentokil Initial (RTO) 323.20p 1.00%
FTSE 100 - Fallers
Entain (ENT) 627.80p -3.27%
Coca-Cola HBC AG (CDI) (CCH) 3,364.00p -3.22%
Hiscox Limited (DI) (HSX) 1,114.00p -3.05%
Melrose Industries (MRO) 502.80p -2.93%
Diploma (DPLM) 3,956.00p -2.80%
NATWEST GROUP (NWG) 434.60p -2.58%
Intertek Group (ITRK) 4,868.00p -2.52%
Croda International (CRDA) 3,102.00p -2.51%
Persimmon (PSN) 1,164.00p -2.51%
Hikma Pharmaceuticals (HIK) 2,020.00p -2.51%
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.